APA (7th ed.) Citation

QIN, Y., SANCHEZ, N. D., ACOSTA, F. M., MOODY, A., NEPPALA, S., TRIPLITT, C. L., . . . SOLIS-HERRERA, C. (2024). 910-P: Novel Mechanism of Action Associated with SGLT2 Inhibition, Peripheral Energy Utilization, and CV Benefits in Subjects with Type 2 Diabetes Mellitus and HFrEF. Diabetes (New York, N.Y.), 73(Supplement_1), 1. https://doi.org/10.2337/db24-910-P

Chicago Style (17th ed.) Citation

QIN, YUEJUAN, et al. "910-P: Novel Mechanism of Action Associated with SGLT2 Inhibition, Peripheral Energy Utilization, and CV Benefits in Subjects with Type 2 Diabetes Mellitus and HFrEF." Diabetes (New York, N.Y.) 73, no. Supplement_1 (2024): 1. https://doi.org/10.2337/db24-910-P.

MLA (9th ed.) Citation

QIN, YUEJUAN, et al. "910-P: Novel Mechanism of Action Associated with SGLT2 Inhibition, Peripheral Energy Utilization, and CV Benefits in Subjects with Type 2 Diabetes Mellitus and HFrEF." Diabetes (New York, N.Y.), vol. 73, no. Supplement_1, 2024, p. 1, https://doi.org/10.2337/db24-910-P.